| Literature DB >> 16957271 |
Brian J Brazeau1, Steven J Gort, Holly J Jessen, Amy J Andrew, Hans H Liao.
Abstract
The development of lysine 2,3-aminomutase as a robust biocatalyst hinges on the development of an in vivo activation system to trigger catalysis. This is the first report to show that, in the absence of chemical reductants, lysine 2,3-aminomutase activity is dependent upon the presence of flavodoxin, ferredoxin, or flavodoxin-NADP(+) reductase.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16957271 PMCID: PMC1563663 DOI: 10.1128/AEM.01143-06
Source DB: PubMed Journal: Appl Environ Microbiol ISSN: 0099-2240 Impact factor: 4.792